vs

Side-by-side financial comparison of Ascendis Pharma A/S (ASND) and National Energy Services Reunited Corp. (NESR). Click either name above to swap in a different company.

National Energy Services Reunited Corp. is the larger business by last-quarter revenue ($295.3M vs $267.3M, roughly 1.1× Ascendis Pharma A/S). On growth, Ascendis Pharma A/S posted the faster year-over-year revenue change (42.3% vs -12.2%).

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

National Energy Services Reunited Corp. is a leading integrated oilfield services provider offering a full suite of solutions covering well construction, completion, production, and intervention services for upstream oil and gas operators. Its core markets cover the Middle East, North Africa, and East Asia, serving both national oil companies and international energy clients.

ASND vs NESR — Head-to-Head

Bigger by revenue
NESR
NESR
1.1× larger
NESR
$295.3M
$267.3M
ASND
Growing faster (revenue YoY)
ASND
ASND
+54.5% gap
ASND
42.3%
-12.2%
NESR

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASND
ASND
NESR
NESR
Revenue
$267.3M
$295.3M
Net Profit
$17.7M
Gross Margin
90.5%
12.0%
Operating Margin
6.6%
Net Margin
6.0%
Revenue YoY
42.3%
-12.2%
Net Profit YoY
-14.0%
EPS (diluted)
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASND
ASND
NESR
NESR
Q4 25
$267.3M
Q3 25
$230.7M
$295.3M
Q2 25
$170.7M
$327.4M
Q1 25
$109.0M
$303.1M
Q4 24
$187.8M
Q3 24
$62.5M
$336.2M
Q2 24
$38.9M
$325.0M
Q1 24
$103.6M
Net Profit
ASND
ASND
NESR
NESR
Q4 25
Q3 25
$-65.9M
$17.7M
Q2 25
$-42.0M
$15.2M
Q1 25
$-102.2M
$10.4M
Q4 24
Q3 24
$-107.1M
$20.6M
Q2 24
$-118.1M
$18.9M
Q1 24
$-141.5M
Gross Margin
ASND
ASND
NESR
NESR
Q4 25
90.5%
Q3 25
89.5%
12.0%
Q2 25
80.1%
13.4%
Q1 25
82.6%
12.4%
Q4 24
91.9%
Q3 24
80.6%
15.9%
Q2 24
68.2%
16.4%
Q1 24
92.1%
Operating Margin
ASND
ASND
NESR
NESR
Q4 25
Q3 25
5.1%
6.6%
Q2 25
-33.5%
8.3%
Q1 25
-103.2%
6.9%
Q4 24
Q3 24
-167.3%
10.5%
Q2 24
-370.2%
10.5%
Q1 24
-51.2%
Net Margin
ASND
ASND
NESR
NESR
Q4 25
Q3 25
-28.5%
6.0%
Q2 25
-24.6%
4.6%
Q1 25
-93.7%
3.4%
Q4 24
Q3 24
-171.5%
6.1%
Q2 24
-303.9%
5.8%
Q1 24
-136.6%
EPS (diluted)
ASND
ASND
NESR
NESR
Q4 25
Q3 25
$0.18
Q2 25
$0.16
Q1 25
$0.11
Q4 24
Q3 24
$0.22
Q2 24
$0.20
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASND
ASND
NESR
NESR
Cash + ST InvestmentsLiquidity on hand
$665.3M
$69.7M
Total DebtLower is stronger
$274.1M
Stockholders' EquityBook value
$-175.8M
$956.7M
Total Assets
$1.4B
$1.8B
Debt / EquityLower = less leverage
0.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASND
ASND
NESR
NESR
Q4 25
$665.3M
Q3 25
$582.2M
$69.7M
Q2 25
$533.6M
$131.8M
Q1 25
$559.4M
$78.7M
Q4 24
$604.3M
Q3 24
$675.6M
$118.2M
Q2 24
$279.4M
$75.0M
Q1 24
$345.9M
Total Debt
ASND
ASND
NESR
NESR
Q4 25
Q3 25
$274.1M
Q2 25
$291.7M
Q1 25
$309.2M
Q4 24
Q3 24
$358.7M
Q2 24
$376.7M
Q1 24
Stockholders' Equity
ASND
ASND
NESR
NESR
Q4 25
$-175.8M
Q3 25
$-188.0M
$956.7M
Q2 25
$-202.6M
$936.9M
Q1 25
$-205.0M
$920.5M
Q4 24
$-114.2M
Q3 24
$-105.1M
$873.5M
Q2 24
$-346.8M
$851.4M
Q1 24
$-257.2M
Total Assets
ASND
ASND
NESR
NESR
Q4 25
$1.4B
Q3 25
$1.2B
$1.8B
Q2 25
$1.2B
$1.8B
Q1 25
$1.1B
$1.8B
Q4 24
$1.3B
Q3 24
$1.2B
$1.8B
Q2 24
$819.0M
$1.8B
Q1 24
$866.7M
Debt / Equity
ASND
ASND
NESR
NESR
Q4 25
Q3 25
0.29×
Q2 25
0.31×
Q1 25
0.34×
Q4 24
Q3 24
0.41×
Q2 24
0.44×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASND
ASND
NESR
NESR
Operating Cash FlowLast quarter
$58.2M
$6.7M
Free Cash FlowOCF − Capex
$-34.1M
FCF MarginFCF / Revenue
-11.5%
Capex IntensityCapex / Revenue
13.8%
Cash ConversionOCF / Net Profit
0.38×
TTM Free Cash FlowTrailing 4 quarters
$68.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASND
ASND
NESR
NESR
Q4 25
$58.2M
Q3 25
$6.7M
Q2 25
$98.5M
Q1 25
$-15.5M
$20.5M
Q4 24
$-330.7M
Q3 24
$70.8M
Q2 24
Q1 24
$-109.7M
Free Cash Flow
ASND
ASND
NESR
NESR
Q4 25
Q3 25
$-34.1M
Q2 25
$68.7M
Q1 25
$-9.6M
Q4 24
Q3 24
$43.4M
Q2 24
Q1 24
FCF Margin
ASND
ASND
NESR
NESR
Q4 25
Q3 25
-11.5%
Q2 25
21.0%
Q1 25
-3.2%
Q4 24
Q3 24
12.9%
Q2 24
Q1 24
Capex Intensity
ASND
ASND
NESR
NESR
Q4 25
Q3 25
13.8%
Q2 25
9.1%
Q1 25
9.9%
Q4 24
Q3 24
8.1%
Q2 24
Q1 24
Cash Conversion
ASND
ASND
NESR
NESR
Q4 25
Q3 25
0.38×
Q2 25
6.48×
Q1 25
1.97×
Q4 24
Q3 24
3.43×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASND
ASND

Segment breakdown not available.

NESR
NESR

Production Services$174.4M59%
Drilling And Evaluation Services$120.9M41%

Related Comparisons